GOBO: Gene Expression-Based Outcome for Breast Cancer Online

By Markus Ringnér, E. Fredlund, J. Häkkinen, Å. Borg, J. Staaf. PLoS ONE, 2011

387 citations recorded by the source corpus.

Microarray-based gene expression analysis holds promise of improving prognostication and treatment decisions for breast cancer patients. However, the heterogeneity of breast cancer emphasizes the need for validation of prognostic gene signatures in larger sample sets stratified into relevant subgroups. Here, we describe a multifunctional user-friendly online tool, GOBO (http://co.bmc.lu.se/gobo), allowing a range of different analyses to be performed in an 1881-sample breast tumor data set, and a 51-sample breast cancer cell line set, both generated on Affymetrix U133A microarrays. GOBO supports a wide range of applications including: 1) rapid assessment of gene expression levels in subgroups of breast tumors and cell lines, 2) identification of co-expressed genes for creation of potential metagenes, 3) association with outcome for gene expression levels of single genes, sets of genes, or gene signatures in multiple subgroups of the 1881-sample breast cancer data set. The design and implementation of GOBO facilitate easy incorporation of additional query functions and applications, as well as additional data sets irrespective of tumor type and array platform.

View Paper: https://www.semanticscholar.org/paper/deefe67af3075bcadb1d9a464adb26b869759f27

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Jacques E. Dumont
2. Vincent Detours
3. David Venet

Citations in the corpus

• Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome (2011, background): “Servers resting on these data [41,42] make step #3 accessible to anyone with an Internet connection.”